Effect of the combined administration of imipramine and a monoamine oxidase inhibitor.
D003131:Combined Modality Therapy; D003521:Cyclopropanes / Q000031:analogs & derivatives; D007099:Imipramine; D008996:Monoamine Oxidase Inhibitors; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011600:Psychopharmacology
D003521:Cyclopropanes; D008996:Monoamine Oxidase Inhibitors; C030797:cyclopropane; D010088:Oxidoreductases; D007099:Imipramine
CYCLOPROPANE/related compounds; OXIDASES/antagonists; PSYCHOPHARMACOLOGY/experimental